CCM Duopharma Maintains Positive Results For Q3 FY 2018
Kuala Lumpur – CCM Duopharma Biotech Berhad (CCM Duopharma) grew its Revenue by 7.69 per cent to RM383.09 million from RM355.73 million for the first nine months of its financial year ended September 30, 2018. The Company’s Profit Before Tax (PBT) for the period under review rose 7.80 per cent to RM42.01 million from RM38.97 million.